BlackRock’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.9K | Hold |
16,971
| – | – | ﹤0.01% | 5230 |
|
|
2025
Q4 | $32.8K | Hold |
16,971
| – | – | ﹤0.01% | 5137 |
|
|
2025
Q3 | $35.6K | Hold |
16,971
| – | – | ﹤0.01% | 5035 |
|
|
2025
Q2 | $40.6K | Hold |
16,971
| – | – | ﹤0.01% | 5030 |
|
|
2025
Q1 | $49K | Hold |
16,971
| – | – | ﹤0.01% | 4925 |
|
|
2024
Q4 | $53K | Hold |
16,971
| – | – | ﹤0.01% | 4936 |
|
|
2024
Q3 | $55K | Buy |
16,971
+2
| +0% | +$7 | ﹤0.01% | 4792 |
|
|
2024
Q2 | $68.4K | Sell |
16,969
-16,039
| -49% | -$77.7K | ﹤0.01% | 4790 |
|
|
2024
Q1 | $194K | Sell |
33,008
-546
| -2% | -$2.67K | ﹤0.01% | 4589 |
|
|
2023
Q4 | $124K | Sell |
33,554
-196
| -0.6% | -$896 | ﹤0.01% | 4753 |
|
|
2023
Q3 | $187K | Sell |
33,750
-922
| -3% | -$7.59K | ﹤0.01% | 4695 |
|
|
2023
Q2 | $379K | Sell |
34,672
-17,540
| -34% | -$208K | ﹤0.01% | 4564 |
|
|
2023
Q1 | $652K | Sell |
52,212
-7,496
| -13% | -$99.5K | ﹤0.01% | 4469 |
|
|
2022
Q4 | $595K | Buy |
59,708
+668
| +1% | +$7.47K | ﹤0.01% | 4567 |
|
|
2022
Q3 | $709K | Sell |
59,040
-459
| -0.8% | -$6.3K | ﹤0.01% | 4612 |
|
|
2022
Q2 | $878K | Buy |
59,499
+9,329
| +19% | +$140K | ﹤0.01% | 4589 |
|
|
2022
Q1 | $897K | Buy |
50,170
+19,521
| +64% | +$369K | ﹤0.01% | 4702 |
|
|
2021
Q4 | $735K | Buy |
30,649
+20,422
| +200% | +$420K | ﹤0.01% | 4757 |
|
|
2021
Q3 | $205K | Sell |
10,227
-1,015
| -9% | -$20K | ﹤0.01% | 4982 |
|
|
2021
Q2 | $255K | Buy |
11,242
+11,188
| +20,719% | +$191K | ﹤0.01% | 4848 |
|
|
2021
Q1 | $1K | Hold |
54
| – | – | ﹤0.01% | 5225 |
|
|
2020
Q4 | $1K | Hold |
54
| – | – | ﹤0.01% | 5008 |
|
|
2020
Q3 | $1K | Hold |
54
| – | – | ﹤0.01% | 4973 |
|
|
2020
Q2 | $1K | Hold |
54
| – | – | ﹤0.01% | 4940 |
|
|
2020
Q1 | $1K | Hold |
54
| – | – | ﹤0.01% | 4886 |
|
|
2019
Q4 | $1K | Hold |
54
| – | – | ﹤0.01% | 4912 |
|
|
2019
Q3 | $1K | Hold |
54
| – | – | ﹤0.01% | 4902 |
|
|
2019
Q2 | $1K | Hold |
54
| – | – | ﹤0.01% | 4943 |
|
|
2019
Q1 | $1K | Hold |
54
| – | – | ﹤0.01% | 4855 |
|
|
2018
Q4 | $0 | Hold |
54
| – | – | ﹤0.01% | 4968 |
|
|
2018
Q3 | $1K | Hold |
54
| – | – | ﹤0.01% | 4923 |
|
|
2018
Q2 | $1K | Hold |
54
| – | – | ﹤0.01% | 4940 |
|
|
2018
Q1 | $1K | Hold |
54
| – | – | ﹤0.01% | 4845 |
|
|
2017
Q4 | $1K | Hold |
54
| – | – | ﹤0.01% | 4847 |
|
|
2017
Q3 | $2K | Buy |
54
+1
| +2% | +$49 | ﹤0.01% | 4832 |
|
|
2017
Q2 | $3K | Sell |
53
-439
| -89% | -$25.5K | ﹤0.01% | 4851 |
|
|
2017
Q1 | $47K | Buy |
+492
| New | +$71K | ﹤0.01% | 4477 |
|
Other funds holding DARE
VCM
VFT
XT
BlackRock's DARE Position: Q1 2026 in Review
BlackRock held its Dare Bioscience (DARE) position steady in Q1 2026 at 16,971 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5230.
BlackRock first reported a position in DARE in Q1 2017 and has held it in 37 quarters since. The position peaked at $897K in Q1 2022. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.
- BlackRock held 16,971 shares of Dare Bioscience worth $30.9K as of Q1 2026.
- BlackRock left its Dare Bioscience share count unchanged in Q1 2026.
- Dare Bioscience made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5230 holding.
- BlackRock first reported a position in Dare Bioscience in Q1 2017 and has held it in 37 quarters since.
- BlackRock's Dare Bioscience position peaked at $897K in Q1 2022.
- 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.